VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NANano Labs Ltd
$1.72$116M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. NA
  4. Financial Ratios

Nano Labs Ltd (NA) Financial Ratios

Latest Ratios: P/E Ratio -7.0x · EV/EBITDA N/A · ROE -104.5%. (2019–2024 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

NA Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Market Cap$116M$606M$1.1B$617M———
Enterprise Value$141M$772M$1.2B$553M———
P/E Ratio →-6.99——1.97———
P/S Ratio19.4714.9213.610.63———
P/B Ratio3.392.60—3.75———
P/FCF———————
P/OCF———————

P/E links to full P/E history page with 30-year chart

NA EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
EV / Revenue—19.0214.920.56———
EV / EBITDA———22.47———
EV / EBIT———2.70———
EV / FCF———————

NA Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Gross Margin28.6%28.6%-132.1%23.4%-10.4%40.3%—
Operating Margin-242.7%-242.7%-332.9%2.1%-453.3%-1735.9%—
Net Profit Margin-278.8%-278.8%-322.7%3.2%-443.6%-1772.9%—

Return on Capital

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
ROE-104.5%-104.5%-341.3%44.5%———
ROA-23.4%-23.4%-70.5%4.9%-36.0%-90.5%-50.4%
ROIC-30.4%-30.4%-209.5%————
ROCE-38.3%-38.3%-179.0%25.7%———

NA Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Debt / Equity0.850.85—0.14———
Debt / EBITDA———0.96———
Net Debt / Equity—0.71—-0.39———
Net Debt / EBITDA———-2.61———
Debt / FCF————-3.59—-0.44
Interest Coverage-14.25-14.25-283.45—-350.72-9852.14—

NA Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Current Ratio1.751.750.521.570.960.540.63
Quick Ratio1.611.610.461.020.730.470.63
Cash Ratio1.311.310.210.500.290.330.33
Asset Turnover—0.070.222.680.040.03—
Inventory Turnover0.970.9714.127.370.200.18—
Days Sales Outstanding—462.178.108.81306.11200.07—

NA Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Dividend Yield———————
Payout Ratio———————

Total Shareholder Return Metrics

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Earnings Yield———50.8%———
FCF Yield———————
Buyback Yield0.0%0.0%0.0%0.0%———
Total Shareholder Yield0.0%0.0%0.0%0.0%———
Shares Outstanding—$68M$59M$54M$52M$52M$40M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Existential liquidity and insolvency

Distressed Pricing Reflects Operational Uncertainty

Based on reported figures, Nano Labs trades at a price-to-sales ratio of 19.47, a valuation that appears disconnected from the company's -48.18% revenue decline and suggests investors are pricing the equity as a speculative option on a potential, yet unproven, turnaround in crypto-mining hardware demand.

The extreme P/S multiple relative to the company's contracting revenue base suggests that the market may be assigning value to the firm's intellectual property or potential pivot to AI-related hardware rather than its current transactional business. Investors should monitor whether this premium can be sustained as the company continues to report significant net losses and fails to demonstrate a clear path to profitability.

Persistent Decay in Capital Efficiency

As reported in financial statements, Nano Labs' ROIC has remained deeply negative, reaching -2.0% in 2025Q2, which indicates that the company is consistently destroying shareholder value rather than compounding it through its specialized semiconductor design and manufacturing activities.

The inability to generate positive returns on invested capital appears structural, driven by a combination of high R&D overhead and a failure to achieve the scale necessary to amortize fixed costs. This trend suggests that the firm's current capital allocation strategy is failing to produce a competitive advantage, warranting further investigation into the viability of its long-tail crypto-asset focus.

Working Capital Management Remains Strained

According to recent quarterly data, the company's cash conversion cycle has ballooned to 531 days, a figure that highlights severe inefficiencies in inventory management and suggests that Nano Labs is struggling to move its specialized hardware in a market characterized by rapidly shifting network protocols.

The exceptionally high days inventory outstanding, which reached 1378 days in 2025Q2, implies that the company is holding significant amounts of potentially obsolete hardware. This inventory overhang poses a material risk to future margins, as the firm may be forced to take aggressive write-downs to clear stock in an increasingly competitive semiconductor landscape.

Debt Burden Outpaces Operational Capacity

Based on the latest quarterly filings, Nano Labs' debt-to-equity ratio has risen to 1.11, a level that appears increasingly unsustainable given the company's negative interest coverage ratio of -6.85 and its ongoing inability to generate positive operating cash flow to service these mounting financial obligations.

The reliance on debt financing to sustain operations in the face of persistent losses suggests that the company's balance sheet is becoming increasingly vulnerable to credit market volatility. Investors should monitor the firm's ability to refinance these obligations, as the current trajectory may necessitate further dilutive equity raises to avoid a liquidity crisis.

Misapplication of Price-to-Book Multiples

The price-to-book ratio of 3.39 is frequently misapplied to Nano Labs, as it obscures the reality that the company's book value is heavily influenced by recent dilutive financing rather than the accumulation of productive, income-generating assets within its fabless semiconductor business model.

Relying on P/B in this context is misleading because it ignores the rapid erosion of equity through accumulated deficits and the high probability of future inventory write-downs. A more appropriate focus would be on the company's cash burn rate and its ability to maintain liquidity, as these metrics provide a clearer picture of the firm's survival prospects than accounting-based book value.

Download Financial Ratios Data

Includes 30+ ratios · 6 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NA — Frequently Asked Questions

Quick answers to the most common questions about buying NA stock.

What is Nano Labs Ltd's P/E ratio?

Nano Labs Ltd's current P/E ratio is -7.0x. The historical average is 2.0x.

What is Nano Labs Ltd's ROE?

Nano Labs Ltd's return on equity (ROE) is -104.5%. The historical average is -133.8%.

Is NA stock overvalued?

Based on historical data, Nano Labs Ltd is trading at a P/E of -7.0x. Compare with industry peers and growth rates for a complete picture.

What are Nano Labs Ltd's profit margins?

Nano Labs Ltd has 28.6% gross margin and -242.7% operating margin.